Please Wait...

William Hogan

Translation skills

Main profile

William Hogan
Executive Vice President & Chief Financial Officer

William Hogan joins Bioclinica as EVP and CFO from Multi Packaging Solutions (“MPS”), a multinational, $2 billion manufacturer of specialty packaging for the pharmaceutical and consumer products industries. He was CFO for 12 years and served on the leadership team that managed MPS’s global expansion through several transactions including the sale of the business. His experience meeting the needs of the world’s top pharmaceutical companies will provide great insight into serving Bioclinica customers. Prior to MPS, Hogan held CFO roles in multinational product and services-based businesses, both public reporting companies and private equity owned organizations, as well as 12 years with Deloitte. He is a certified public accountant and has extensive experience in the strategic, financial and operational management of multinational organizations. He brings a strong track record of increasing shareholder value and meeting the challenges created by evolving companies and rapidly changing economic and competitive environments. Bill brings with him significant CFO experience from a variety of different businesses and his experience with over 19 acquisitions transactions will be an asset to Bioclinica.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil… https://t.co/77NOME2Dj7
bioclinica (21 hours ago)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace… https://t.co/f9vtRpsbMW
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c… https://t.co/PAdROjo7tE
bioclinica (Yesterday)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg https://t.co/cAewLypUY7
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus https://t.co/jgwaqxfiXl #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '… https://t.co/NxauNywq23
bioclinica (6 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen